ArticleWorld journal of clinical cases2018

Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study.

Xue-Fen Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.